Biography

Roland Diggelmann (Born 1967, Swiss citizen) has been a non-executive member of the Board of Directors since 2021.

From 2019 until March 31, 2022, he has been CEO of Smith & Nephew plc, a UK-based leading global medical technology company active in orthopedics, sports medicine, and advanced wound management. From 2008 to 2012 he was managing director for the Asia / Pacific region and from 2012 until 2018 CEO of Roche Diagnostics. He previously held senior management positions in sales and marketing as well as strategic planning at Zimmer Holdings and Sulzer Medica (later known as Centerpulse).

With more than 20 years of executive experience in the medical device industry across many parts of the world and as CEO, Roland Diggelmann provides valuable input to the implementation of Sonova’s strategy. 

Roland Diggelmann studied Business Administration at the University of Bern, Switzerland.

Committee Memberships

He serves as member and chair on the Nomination and Compensation Committee. 

Outside mandates

Listed companies: 

• Chair of the Board of Directors of Mettler Toledo International Inc.

Other mandates:

• Member of the Board of Directors of Berlin Heals AG
• Member of the Board of Directors of HeartForce AG
• Member of the Board of Directors of Navignostics AG
• Member of the Board of Directors of Osler Diagnostics Ltd.

Holdings as per 31.03.2025

• Shares: 2,238
• Restricted Shares¹⁾: 2,238

1) These shares are subject to a restriction period which varies from June 1, 2025 to June 1, 2030 depending on the grant date. For further details see also Note 7.4 in the consolidated financial statements.